Associate Professor, Urology, Tufts University School of Medicine
Urology
Dr. David R. Staskin, MD
|
|
Give Review
David R. Staskin, MD is an expert in the field of Urology. He attended Drexel University College of Medicine. He received 4 awards: "Boston Magazine", "CMS Meaningful Use Stage 1 Certification", "Top Doctors: New York Metro Area" and "Super Doctor". Doctor David R. Staskin, MD is a published physician as well. He has 100 publications published. The latest was: Urinary Incontinence in Women. He is registered with Medicare and accepts Medicare payments.
Publications
- Clinical safety, tolerability and efficacy of combination tolterodine/pilocarpine in patients with overactive Bladder.
- The Evaluation and Treatment of Prostate-Related LUTS in the Primary Care Setting: The Next STEP.
- Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive Bladder syndrome symptoms.
- Efficacy and safety of tolterodine extended release and dutasteride in male overactive Bladder patients with prostates >30 grams.
- Extended-release trospium chloride improves quality of life in overactive Bladder.
- Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive Bladder.
- Surgical options for drug-refractory overactive Bladder patients.
- Re: Benign prostatic obstruction and Parkinson's disease--should transurethral resection of the Prostate be avoided? B. Roth, U. E. Studer, C. J. Fowler and T. M. Kess...
- Efficacy and safety of oxybutynin chloride topical gel for overactive Bladder: a randomized, double-blind, placebo controlled, multicenter study.
- Urinary retention and post-void residual Urine in men: separating truth from tradition.
- Trospium 60 mg once daily (QD) for overactive Bladder syndrome: results from a placebo-controlled interventional study.
- Anticholinergics and central nervous system effects: are we confused?
- Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive Bladder.
- Antimuscarinic therapy in men with Bladder outlet obstruction.
- Stimulating aspects of sacral nerve stimulation.
- Transdermal delivery of drugs for urologic applications: basic principles and applications.
- Using anticholinergics to treat overactive Bladder: the issue of treatment tolerability.
- Pharmacologic management of overactive Bladder: practical options for the primary care physician.
- Management of Incontinence for family practice physicians.
- Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
- The Q-T interval and antimuscarinic drugs.
- Mixed Incontinence: the misclassification of patients and limitations of clinical trials.
- A validated patient reported measure of urinary urgency severity in overactive Bladder for use in clinical trials.
- The urge to define urgency: a review of three approaches.
- Effect of trospium chloride on somnolence and sleepiness in patients with overactive Bladder.
- Systematic review of anticholinergic agents: clinical trials versus clinical effectiveness.
- Trospium chloride: a quaternary amine with unique pharmacologic properties.
- Nocturia: when is it not related to overactive Bladder?
- Artificial graft slings at the midurethra: physiology of continence.
- Transdermal systems for overactive Bladder: principles and practice.
- Methodologic shortcomings inherent in a post-hoc analysis.
- Advances in drug delivery: improved bioavailability and drug effect.
- Overview consensus statement.
- Future studies of overactive Bladder: the need for standardization.
- Synthetic slings: pros and cons.
- Autologous and synthetic urethral slings for female Incontinence.
- Mechanisms of continence and surgical cure in Female and male SUI: surgical research initiatives.
- Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive Bladder.
- Trospium chloride is undetectable in the older human central nervous system.
- Modeling dose-response relationships of the effects of fesoterodine in patients with overactive Bladder.
- Female pelvic surgical devices and techniques need better evidence-based medicine.
- Efficacy of fesoterodine over 24 hours in subjects with overactive Bladder.
- Once daily trospium chloride is effective and well tolerated for the treatment of overactive Bladder: results from a multicenter phase III trial.
- The overactive Bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive b...
- Mixed Incontinence: definitions, outcomes, and interventions.
- Transdermal oxybutynin in the treatment of adults with overactive Bladder: combined results of two randomized clinical trials.
- Oxybutynin chloride: alterations in drug delivery and improved therapeutic index.
- Genuine stress Incontinence theories of etiology and surgical correction.
- Overactive Bladder in men: special considerations for evaluation and management.
- Clinical versus urodynamic diagnosis in an incontinent geriatric Female population.
- [Urethral replacement in women. Experimental works and clinical application].
- Effect of a Urinary control insert on quality of life in incontinent women.
- Prospective evaluation of an assessment strategy for geriatric Urinary incontinence.
- Simple versus multichannel cystometry in the evaluation of Bladder function in an incontinent geriatric population.
- Surgery for Pelvic prolapse.
- Transvaginal closure of the Bladder neck.
- GenitoUrinary fistulas: vaginal approach for repair of vesicovaginal fistulas.
- Urological complications secondary to a contraceptive diaphragm.
- Effectiveness of a Urinary control insert in the management of stress Urinary incontinence: early results of a multicenter study.
- Urinary Incontinence in Women.
- Overactive Bladder medication switch studies--vive le différence?
- Urinary urgency - translating the evidence base into daily clinical practice.
- Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of Urinary incontinence, pelvic o...
- Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive Bladder.
- Oxybutynin topical and transdermal formulations: an update.
- STEP: simplified treatment of the Enlarged prostate.
- Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive Bladder syndrome: an integrated analysis of two randomise...
- Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive Bladder and prostate conditions.
- Baseline Incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
- The five ''Ps'' of an Incontinence clinical practice guideline.
- Urology: needle urethral-vesical suspensions for stress Incontinence.
- A practical guide to the evaluation and treatment of male lower Urinary tract symptoms in the primary care setting.
- Clinical usefulness of Urinary control urethral insert devices.
- Pelvic floor electrical stimulation for the treatment of urge and mixed Urinary incontinence in women.
- The Gore-tex sling procedure for female sphincteric Incontinence: indications, technique, and results.
- Patient satisfaction with a reusable undergarment for Urinary incontinence.
- Cues to action: pelvic floor muscle exercise compliance in women with stress Urinary incontinence.
- Urinary incontinence: steps to evaluation, diagnosis, and treatment.
- Use of synthetic material in sling surgery: a minimally invasive approach.
- History, physical examination, and classification of neurogenic voiding Dysfunction.
- Pelvic floor electrical stimulation: a comparison of daily and every-other-day therapy for genuine stress Incontinence.
- Abnormal detrusor function precipitating hydronephrosis identified by extended voiding cystometry.
- Intraperitoneal Bladder rupture after normal vaginal delivery.
- Pelvic floor electrical stimulation in the treatment of genuine stress Incontinence: a multicenter, placebo-controlled trial.
- Bladder transection--a functional, neurophysiological, neuropharmacological and neuroanatomical study.
- A new technique for Chronic catheterization of female dogs.
- Analysis of the anticholinergic and musculotropic effects of desmethylimipramine on the rabbit urinary Bladder.
- Pathophysiology of stress Incontinence.
- The pathophysiology of stress Incontinence.
- Transvaginal needle Bladder neck suspension.
- Preoperative, intraoperative, and postoperative management of Vaginal surgery.
- Complications of Vaginal surgery.
- Vesicovaginal and urethrovaginal Fistulae.
- Anatomy for Vaginal surgery.
- GenitoUrinary fistulae. Vaginal approach for repair of vesicovaginal fistulae.
- Office evaluation of female Urinary incontinence.
- Operative correction for Female urethral incompetence.
- Urinary incontinence in the elderly.
- Surgical treatment of Female urethral diverticulum.
Schools
Drexel University College of Medicine
University Of California San Diego
University Ca San Diego Med Center
University Of Pa Health System
University Of Pennsylvania
University Calif
Procedures Preformed
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Incontinence Sling Procedure
- Penile Implants
- TURP (Transurethral Resection of Prostate) or Laser Destruction of Prostate
Conditions Treated
- Atrophic Vaginitis
- Bladder Cancer
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Boston Magazine
- CMS Meaningful Use Stage 1 Certification
- Top Doctors: New York Metro Area
- Super Doctor
Education
-
University of Pennsylvania Health System -
University of California San Diego -
Drexel University College of Medicine
Drug Facts
| NPI NUMBER | 1629165717 | |
| NPPES Provider LastName | STASKIN | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 100214870 | |
| NPPES Provider State | NY | |
| Specialty Description | Urology | |
| Total Claim Count | 93.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629165717 |
| Last Name Of The Provider | STASKIN |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Michael G. Callum, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonid Kotkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin M. Tomera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace Thomas, MD |
|
|
Dr. Christopher R. Hoover, MD |
|
|
Dr. Abdulsalam A. Albalawi, MD |
|
|
Dr. Persis O. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander W. Pang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Abdulrahman A. Babaeer, MB BS |